Infinity Pharmaceuticals Inc (NASDAQ:INFI)
| 2.46 BATS BZX Real-Time Price As of 3:21pm ET |  -0.07 / -2.77%Today’s Change | 1.04 Today|||52-Week Range 5.98 | +16.04% Year-to-Date |
Latest INFI News | Press Releases
| Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today Oct 18 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.53 |
| Today’s open | 2.52 |
| Day’s range | 2.46 - 2.53 |
| Volume | 16,995 |
| Average volume (3 months) | 5,858,861 |
| Market cap | $230.7M |
Data as of 3:21pm ET, 10/27/2021
Growth & Valuation
| Earnings growth (last year) | +18.08% |
| Earnings growth (this year) | +18.57% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -43.62% |
| P/E ratio | NM |
| Price/Sales | 73.82 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ESPREsperion Therapeutic... | +0.48 | +6.03% |
| IMUXImmunic Inc | +0.04 | +0.46% |
| ORTXOrchard Therapeutics... | +0.02 | +1.34% |
| MBIOMustang Bio Inc | -0.16 | -6.68% |
Data as of 3:23pm ET, 10/27/2021
Financials
| Next reporting date | November 9, 2021 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $1.7M |
| Annual profit (last year) | -$40.5M |
| Net profit margin | -2,355.56% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
